Vivekanand Jha's Publications

About Vivekanand Jha's Publications

Executive Director, The George Institute for Global Health, India
  • MD,
  • DM,
  • FRCP,
  • FAMS

  • Investigating Kidney Disease

    Management of Kidney Diseases Date published:

  • The Approach to the Patient with Kidney Disease

    Management of Kidney Diseases Date published:

  • Management of Kidney Diseases

    Management of Kidney Diseases Date published:

  • Prophylaxis for Patients at Risk of COVID-19 Infection: Results from the Intranasal Niclosamide Randomised, Double Blinded, Placebo Controlled Arm of the PROTECT-V Platform Trial

    Unknown Date published:

  • Renin-angiotensin blocker use is associated with improved cardiovascular mortality in Indian patients with mild-moderate chronic kidney disease-findings from the ICKD study

    Frontiers in Medicine Date published:

  • ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial

    Trials Date published:

  • Heterogeneity of treatment effect of higher dose dexamethasone by geographic region in patients with COVID-19 and severe hypoxemia - A post hoc evaluation of the COVID STEROID 2 trial

    Unknown Date published:

  • Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial

    BMJ Date published:

  • Heterogeneous treatment effects of dexamethasone 12 mg versus 6 mg in patients with COVID -19 and severe hypoxaemia-Post hoc exploratory analyses of the COVID STEROID 2 trial

    Acta Anaesthesiologica Scandinavica Date published:

  • Potential effects of lowering the threshold of statistical significance in the field of chronic rhinosinusitis - A meta-research on published randomized controlled trials over last decade

    Brazilian Journal of Otorhinolaryngology Date published:

  • Chronology of disc degeneration and facet joint arthritis in lumbar spine is variable - A CT based cross-sectional study

    Journal of Orthopaedic Science Date published:

  • Barriers to accessing essential medicines for kidney disease in low- and lower middle-income countries|

    Kidney International Date published:

  • The Reality of Inadequate Patient Care and the Need for a Global Action Framework in Organ Donation and Transplantation

    Transplantation Date published:

  • SGLT2 Inhibitors in the Management of Chronic Kidney Disease: An Expert Consensus

    Journal of the Association of Physicians of India Date published:

  • Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases: A Scientific Workshop Cosponsored by the National Kidney Foundation and the US Food and Drug Administration

    American Journal of Kidney Diseases Date published:

  • Evaluation and Management of Tuberculosis in Solid Organ Transplant Recipients

    Indian Journal of Transplantation Date published: